US Broker Ratings

Artivion, Inc. (AORT) Stock Analysis: Strong Buy Ratings Highlight Potential in Medical Devices

Artivion, Inc. (NASDAQ: AORT), a rising player in the medical devices sector, has captured the attention of investors with its innovative products and strategic market positioning...

agilon health, inc. (AGL) Stock Analysis: Is an 85.75% Upside Within Reach for Healthcare Investors?

agilon health, inc. (NYSE: AGL), a prominent player in the U.S. healthcare sector, specializes in providing comprehensive healthcare services to seniors through a network of primary..

NeoGenomics, Inc. (NEO) Stock Analysis: Growth Potential and Analyst Insights

As an investor in the ever-evolving healthcare sector, it’s crucial to stay informed about companies that are making strides in diagnostics and research. One such company..

Pulse Biosciences, Inc (PLSE): Investor Outlook on Its Promising 45.99% Upside Potential

Pulse Biosciences, Inc. (NASDAQ: PLSE) is attracting attention in the healthcare sector with its innovative bioelectric medicine solutions. Operating within the United States, the company is..

National HealthCare Corporation (NHC) Stock Analysis: Exploring Growth Amidst A Robust Revenue Surge

National HealthCare Corporation (NYSE: NHC), a prominent player in the U.S. healthcare sector, operates across a diverse range of medical care facilities. With a market capitalization..

Tarsus Pharmaceuticals Inc. (TARS) Stock Analysis: Uncovering 72.99% Potential Upside in Eye Care Biotech

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a commercial-stage biopharmaceutical company based in Irvine, California, is capturing investor attention with its focus on innovative therapeutic candidates for eye..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Strong Buy Ratings and Promising Growth Trajectory

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a key player in the biotechnology sector, has captured investor attention with its promising growth metrics and robust pipeline targeting autoimmune..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Unveiling 130% Potential Upside Amid RNA Breakthroughs

Wave Life Sciences Ltd. (NASDAQ: WVE) stands at the forefront of innovation in the biotechnology sector, leveraging its PRISM platform to develop cutting-edge RNA medicines. Based..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 101.69% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is making waves in the healthcare sector with its focus on innovative diabetes management solutions. Specializing in medical devices, Tandem..

Vera Therapeutics (VERA) Stock Analysis: Understanding Its 217% Upside Potential

Investors seeking opportunities in the healthcare sector might find Vera Therapeutics, Inc. (VERA) an intriguing prospect. This clinical-stage biotechnology company, headquartered in Brisbane, California, is committed..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 40% Potential Upside and Market Positioning

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands at an intriguing crossroads for investors, poised for a potential upside of 40.37% based on the average target price of..

Azenta, Inc. (AZTA) Stock Analysis: Navigating a Challenging Market with a 4.91% Potential Upside

Azenta, Inc. (AZTA), a prominent player in the healthcare sector under the medical instruments and supplies industry, is making strategic strides in a complex market landscape...

Premier, Inc. (PINC) Stock Analysis: Healthcare Giant with a 3.95% Dividend Yield Offers Modest Upside

Premier, Inc. (NASDAQ: PINC), a key player in the health information services industry, stands out with its robust dividend yield and strategic positioning in the healthcare..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a 245% Potential Upside with Innovative Cancer Therapies

For investors keen on the biotechnology sector, Janux Therapeutics, Inc. (NASDAQ: JANX) presents an intriguing opportunity. With a market capitalization of $1.41 billion and a notable..

NewAmsterdam Pharma (NAMS): Unveiling a 91.71% Potential Upside with Strong Buy Ratings

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is capturing the attention of investors with its promising growth trajectory in the healthcare sector, specifically within the biotechnology industry...

PACS Group, Inc. (PACS) Stock Analysis: A Healthcare Giant with 177% Upside Potential

PACS Group, Inc. (NASDAQ: PACS), a key player in the healthcare sector, has been capturing significant investor attention due to its robust growth prospects and compelling..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 254% Potential Upside

Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage biotech firm headquartered in Waltham, Massachusetts, is drawing significant attention in the healthcare sector with its innovative approach to..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a 51.62% Potential Upside for Investors

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector with its robust growth potential and promising market position. Headquartered in Eagle, Idaho,..

Organon & Co. (OGN) Stock Analysis: Unlocking a Potential 37.88% Upside for Investors

Investors with an eye on the healthcare sector might find Organon & Co. (OGN) an intriguing opportunity as the company’s stock presents a potential upside of..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 26% Potential Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, specifically within the medical devices industry, has captured the attention of investors with..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds